Despite that the TOV-21G cells (TP53 wild-type) showed lower expressions of TNFRSF10B and TNFRSF10C receptors , other mechanisms may be involved in the control of expression of the TRAIL receptor in ovarian tumors. This evidence concerns the gene TP53 and ovarian neoplasm.